Most cancers need that chronically inflamed environment to grow, so suppressing it works against tumor progression
Meet Our Experts Sandy Bassin, MD Medical Reviewer Member of American College of Lifestyle Medicine Sandy Bassin, MD, is an endocrinology fellow at Mount Sinai in New York City
This is one of the most common reasons people transition from liraglutide to tirzepatide
The study in the NEJM showing possible benefits of semaglutide in MASH patients with advanced inflammation and fibrosis is another exciting advance in our efforts to conquer this indolent, but deadly disease.
Finally, surgery in general is traumatic, highly inflammatory and requires much of the bodys resources to heal and repair in a timely and effective manner
Tirzepatide remained the most commonly prescribed GLP-1 RA overall, but semaglutideparticularly AOM semaglutideshowed the greatest increase over the quarter